National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Recruiting Observational Study
Inherited Ophthalmic Diseases Hypopigmentation Disorder Corneal Dystrophy Blue-cone Monochromacy Best Disease Aniridia Albinism
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 120
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
National Eye Institute (NEI) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: The eyeGENE (Registered Trademark) program is a research resource for inherited eye conditions which includes genotypic and phenotypic data, imaging, and a corresponding biobank of DNA samples from people with a variety of eye diseases. Since 2007 this registry has been helping researchers learn more about the genetic sources for many inherited eye diseases. These findings helped them…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: The participant must present with characteristics consistent with one of the following diagnoses: * Aniridia * Best disease * Blue-cone monochromacy * Corneal dystrop…
Contacts

eyeGene Coordinating Center

(301) 435-3032

neieyegeneinfo@nih.gov

CONTACT

Brian P Brooks, M.D.

(301) 451-2238

brooksb@mail.nih.gov

CONTACT